EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudie

Antibiotic prophylaxis to prevent infection in patients with Child–Pugh A cirrhosis with upper gastrointestinal bleed: an open label randomised controlled trial

Anany Gupta, Samagra Agarwal, Sanchit Sharma, Srikanth Gopi, Deepak Gunjan, Anoop Saraya

Hepatology International · 2025-10 · 19 (5) · 1162-1171

DOI: 10.1007/s12072-024-10767-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Hepatology International, online erschienen am 03.01.2025. Verfasst von Anany Gupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Gastrointestinal Hemorrhage, Liver Cirrhosis, Antibiotic Prophylaxis, Bacterial Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Although beneficial in reducing the risk of bacterial infections in patients with advanced decompensated cirrhosis after upper gastrointestinal (GI) bleed, the utility of prophylactic antibiotics in those with Child-Pugh A cirrhosis is not known. We studied if prophylactic antibiotics can be withheld in this cohort. METHODS: This was a single-centre, open-label randomised-controlled-trial with non-inferiority design. Patients of Child-Pugh A cirrhosis with upper-GI bleed and hemodynamic stability were randomised to receive either no prophylactic antibiotics (test-group) or ceftriaxone [standard of care (SOC)] for 72 h alongside standard medical management. The primary outcome was infection at day-5 in both arms. Secondary outcomes included failure to control bleed, mortality at day-5, and at 6 weeks. RESULTS: Eligible patients (n = 180; mean age 45.1 ± 13.1 years, 76.9% males; median MELDNa 9 [interquartile-range: 7-12]) of predominant non-viral etiology (alcohol: 43.4%; non-alcoholic steatohepatitis: 21.7%) were randomised, of whom outcomes could be reliably assessed for 172 and 140 patients at 5-day and 6-week follow-up, respectively. Rate of day-5 infections in test-group [7.0% (95% CI 2.8-15.1%)] was non-inferior to SOC arm [11.6% (95% CI 6.02-20.8%); absolute risk difference: -4.7% (95% CI -13.3% to 4.0%; non-inferior at 10% margin)]. Spontaneous bacterial peritonitis following post-bleed ascites was the most common site of infection in both groups (10/16; 66.7%). Rates of failure to control bleed [0% vs 4.9; absolute-risk-difference: -4.6% (95% CI -9.1% to 0.2%)], day-5 mortality [0% vs 2.5%; absolute-risk-difference: -2.3% (-5.5% to 0.9%)], and 6-week mortality [1.4% vs 2.5%; absolute-risk-difference: -1.6% (-6.5% to 3.2%)] were comparable in both arms. CONCLUSION: Among patients with Child-Pugh A cirrhosis with hemodynamic stability, withholding prophylactic antibiotics after upper GI bleed was not associated with increased risk of post-bleed infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal HemorrhageLiver CirrhosisAntibiotic ProphylaxisBacterial InfectionsAnti-Bacterial AgentsCeftriaxoneHumansMaleFemaleMiddle AgedAdultEsophageal and Gastric Varices

Stichwörter der Autor:innen

AntibioticsChild–Pugh A cirrhosisInfectionRebleedingUpper GI bleed

Substanzen

Anti-Bacterial AgentsCeftriaxone

Autor:innen und Institutionen

  • Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. sanchitsharma2188@gmail.com.
  • Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. ansaraya@yahoo.com.

Zitieren

APA

Gupta, A., Agarwal, S., Sharma, S., Gopi, S., Gunjan, D., & Saraya, A. (2025). Antibiotic prophylaxis to prevent infection in patients with Child–Pugh A cirrhosis with upper gastrointestinal bleed: an open label randomised controlled trial. Hepatology International, 19(5), 1162-1171. https://doi.org/10.1007/s12072-024-10767-2

Vancouver

Gupta A, Agarwal S, Sharma S, Gopi S, Gunjan D, Saraya A. Antibiotic prophylaxis to prevent infection in patients with Child–Pugh A cirrhosis with upper gastrointestinal bleed: an open label randomised controlled trial. Hepatology International. 2025;19(5):1162-1171. doi:10.1007/s12072-024-10767-2

BibTeX
@article{Gupta2025,
  author = {Gupta, Anany and Agarwal, Samagra and Sharma, Sanchit and Gopi, Srikanth and Gunjan, Deepak and Saraya, Anoop},
  title = {Antibiotic prophylaxis to prevent infection in patients with Child–Pugh A cirrhosis with upper gastrointestinal bleed: an open label randomised controlled trial},
  journal = {Hepatology International},
  year = {2025},
  volume = {19},
  number = {5},
  pages = {1162--1171},
  doi = {10.1007/s12072-024-10767-2}
}
Kostenlos starten →